Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,160
+10 (0.10%)
At close: Sep 11, 2026

Ahn-Gook Pharmaceutical Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
56,05238,94915,84428,99118,21913,650
Short-Term Investments
4,3422,3002,3005,05011,0507,496
Trading Asset Securities
4,56612,80211,5941,4059,17326,314
Cash & Short-Term Investments
64,96054,05029,73835,44638,44247,460
Cash Growth
33.03%81.75%-16.10%-7.79%-19.00%-5.59%
Accounts Receivable
33,24328,59858,72262,13254,91743,059
Other Receivables
1,192702.89133.27461.03519.21817.96
Receivables
34,59629,46059,01562,75355,59744,159
Inventory
48,66551,36744,67235,71826,59423,891
Prepaid Expenses
363.86233.86223.64130.7475.0490.25
Other Current Assets
1,4711,6531,1231,3681,302683.49
Total Current Assets
150,055136,765134,772135,416122,010116,285
Property, Plant & Equipment
123,005122,986120,06973,03670,77170,911
Long-Term Investments
28,06525,18228,04322,92723,03726,872
Goodwill
2,9902,990----
Other Intangible Assets
8,4385,5653,9014,2874,0873,874
Long-Term Deferred Tax Assets
4,0433,6452,0861,7222,816843.94
Other Long-Term Assets
13,82113,81913,6641,2081,1931,171
Total Assets
331,018310,953302,535238,598223,912219,956

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
13,09613,79610,26515,20812,64310,141
Accrued Expenses
13,95414,24612,06010,6198,9746,141
Short-Term Debt
27,30022,30027,30017,30019,45019,600
Current Portion of Long-Term Debt
66.666.6--8.2560.93
Current Portion of Leases
305.22264.33197.36259.14336.51296.49
Current Income Taxes Payable
6,205-3,652238.131,369383.15
Current Unearned Revenue
----0.7818.55
Other Current Liabilities
28,04132,25123,58534,61918,71715,572
Total Current Liabilities
88,96882,92377,05978,24261,49852,212
Long-Term Debt
50,08350,11750,000--8.25
Long-Term Leases
309.84327.28226.52120.27210.13225.69
Pension & Post-Retirement Benefits
9,3318,7369,0238,0497,13013,913
Long-Term Deferred Tax Liabilities
71.4875.25----
Other Long-Term Liabilities
2,5232,4851,483520.06402.69316.44
Total Liabilities
151,287144,663137,79286,93269,24166,675

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
6,5216,5216,5216,5216,5216,521
Additional Paid-In Capital
8,3478,33115,53115,53115,53115,531
Retained Earnings
169,503154,601145,070131,553133,487127,754
Treasury Stock
-4,956-4,941-4,941-4,941-4,941-4,387
Comprehensive Income & Other
-702.83862.293,4943,4224,1998,001
Total Common Equity
178,712165,375165,676152,086154,798153,421
Minority Interest
1,018914.47-932.34-420.65-126.44-140.14
Shareholders' Equity
179,730166,289164,743151,666154,671153,281
Total Liabilities & Equity
331,018310,953302,535238,598223,912219,956

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
78,06573,07577,72417,67920,00520,191
Net Cash (Debt)
-13,105-19,024-47,98617,76718,43727,269
Net Cash Growth
----3.63%-32.39%-7.45%
Net Cash Per Share
-1153.04-1673.90-4221.581563.261620.252380.83
Filing Date Shares Outstanding
11.3711.3711.3711.3711.3711.41
Total Common Shares Outstanding
11.3711.3711.3711.3711.3111.41
Working Capital
61,08753,84257,71357,17460,51164,072
Book Value Per Share
15724.2814550.7914577.2513381.5613683.3613441.11
Tangible Book Value
167,285156,821161,774147,799150,711149,547
Tangible Book Value Per Share
14718.8113798.1114233.9813004.3313322.1313101.72
Land
36,75636,75636,75619,50119,50119,501
Buildings
77,13477,52277,09634,39319,51034,222
Machinery
53,02847,49342,52234,06629,97433,184
Construction In Progress
4,0475,891830.0424,21022,71221,973